Market Place
Sourcing Support
Enforcement Report - Week of January 7, 2026
07 Jan 2026 //
FDA
Enforcement Report - Week of December 17, 2025
17 Dec 2025 //
FDA
Enforcement Report - Week of December 10, 2025
10 Dec 2025 //
FDA
Enforcement Report - Week of October 1, 2025.pdf
01 Oct 2025 //
FDA
Glenmark Pharma is on Health Canada Inspection List
25 Sep 2025 //
HEALTH CANADA
Enforcement Report - Week of August 20, 2025
20 Aug 2025 //
FDA
Glenmark Pharmaceuticals Recieves Warning Letter
22 Jul 2025 //
FDA
Enforcement Report - Week of June 18, 2025
18 Jun 2025 //
FDA
Enforcement Report - Week of June 4, 2025
04 Jun 2025 //
FDA
Enforcement Report - Week of May 7, 2025.pdf
07 May 2025 //
FDA
Enforcement Report - Week of April 16, 2025
16 Apr 2025 //
FDA
FDA Issues Form 483 to Glenmark Pharmaceuticals
03 Mar 2025 //
FDA
Enforcement Report - Week of February 26, 2025
26 Feb 2025 //
FDA
Enforcement Report - Week of February 12, 2025
12 Feb 2025 //
FDA
Enforcement Report - Week of January 1, 2025
01 Jan 2025 //
FDA
Enforcement Report - Week of December 11, 2024
11 Dec 2024 //
FDA
Enforcement Report - Week of October 9, 2024
09 Oct 2024 //
FDA
Enforcement Report - Week of October 2, 2024
02 Oct 2024 //
FDA
Enforcement Report for Week of August 7, 2024
07 Aug 2024 //
FDA
Enforcement Report - Week of July 24, 2024
24 Jul 2024 //
FDA
Glenmark USA Issues Voluntary Nationwide Recall for KCL ER Capsule
26 Jun 2024 //
FDA
Enforcement Report - Week of May 1, 2024
01 May 2024 //
FDA
Enforcement Report - Week of April 10, 2024
10 Apr 2024 //
FDA
Enforcement Report - Week of January 31, 2024
31 Jan 2024 //
FDA
Enforcement Report - Week of December 6, 2023
06 Dec 2023 //
FDA
Enforcement Report - Week of November 29, 2023
29 Nov 2023 //
FDA
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Enforcement Report - Week of November 8, 2023
08 Nov 2023 //
FDA
Enforcement Report - Week of July 26, 2023
26 Jul 2023 //
FDA
Glenmark Pharmaceuticals Limited, Unit I on Health Canada Inspection List
15 Feb 2023 //
HEALTH CANADA
Glenmark Pharmaceuticals Limited on Health Canada Inspection List
03 Jan 2023 //
HEALTH CANADA
FDA Issues Form 483 to Glenmark Pharmaceuticals Ltd
28 Dec 2022 //
FDA
Glenmark Pharmaceuticals Receives FDA Warning Letter
07 Dec 2022 //
FDA
Glenmark Pharmaceuticals, Unit I on Health Canada Inspection List
07 Dec 2022 //
HEALTH CANADA
Glenmark Pharmaceuticals on FDA IMport Alert List
26 Oct 2022 //
FDA
Enforcement Report - Week of August 10, 2022
10 Aug 2022 //
FDA
Enforcement Report - Week of July 27, 2022
27 Jul 2022 //
FDA
Enforcement Report - Week of July 13, 2022
13 Jul 2022 //
FDA
Enforcement Report - Week of July 6, 2022
06 Jul 2022 //
FDA
Enforcement Report - Week of May 4, 2022
04 May 2022 //
FDA
Enforcement Report - Week of September 29, 2021
29 Sep 2021 //
FDA
Enforcement Report - Week of January 15, 2020
16 Jan 2020 //
FDA
Enforcement Report - Week of November 6, 2019
06 Nov 2019 //
FDA
Glenmark Pharmaceuticals Limited Receives FDA Warning Letter
15 Oct 2019 //
FDA
Enforcement Report - Week of August 21, 2019
21 Aug 2019 //
FDA
Enforcement Report - Week of August 14, 2019
14 Aug 2019 //
FDA
Enforcement Report - Week of June 19, 2019
19 Jun 2019 //
FDA
Enforcement Report - Week of April 17, 2019
17 Apr 2019 //
FDA
Enforcement Report - Week of January 16, 2019
16 Jan 2019 //
FDA
Enforcement Report - Week of December 26, 2018
26 Dec 2018 //
FDA
FDA Issues Form 483 to Glenmark Pharmaceuticals Ltd.
08 Jun 2018 //
FDA
Enforcement Report - Week of February 7, 2018
07 Feb 2018 //
FDA
US FDA Issues Form 483 to Glenmark Pharmaceuticals
28 Nov 2017 //
BSEINDIA
